6.	Acquisitions

On December 22, 2016, the Company acquired the ANUSOL and RECTINOL (the “Anusol Acquisition”) business from Johnson & Johnson, Inc. for $130. These are the leading hemorrhoid care brands in each market in which they operate, primarily in the U.K., Canada, Australia and South Africa with total annual sales of $24 in 2016. The acquisition was funded with additional short-term borrowings and will be managed in the Consumer International segment.

The preliminary fair values of the net assets acquired are set forth as follows:

	2016
	Anusol
Inventory and other working capital	$	0.5
Trade names and other intangibles		91.7
Goodwill		37.8
Cash purchase price	$	130.0

The life of the amortizable intangible assets recognized from the Anusol Acquisition ranges from 15 - 20 years. The goodwill is a result of expected synergies from combined operations of the acquisition and the Company. Pro forma results are not presented because the impact is not material to the Company’s consolidated financial results.

On January 4, 2016, the Company acquired Spencer Forrest, Inc., the maker of TOPPIK, (the “Toppik Acquisition”), the leading brand of hair building fibers for people with thinning hair. The total purchase price was $175.3. The Company financed the acquisition with short-term borrowings. This brand is managed within the Consumer Domestic and Consumer International segments.

The fair values of the net assets acquired are set forth as follows:

	2016
	Toppik
Inventory and other working capital	$	9.3
Property, plant and equipment and other long-term assets		0.2
Trade names and other intangibles		115.8
Goodwill		52.3
Current liabilities		(2.3	)
Cash purchase price (net of cash acquired)	$	175.3

The life of the amortizable intangible assets recognized from the Toppik Acquisition ranges from 10 - 20 years. The goodwill is a result of expected synergies from combined operations of the acquisition and the Company. Pro forma results are not presented because the impact is not material to the Company’s consolidated financial results.

On January 2, 2015, the Company acquired VI-COR, a manufacturer and seller of feed ingredients for cows, beef cattle, poultry and other livestock for cash consideration of $74.9, and a $5.0 payment to be made after one year if a certain operating performance is achieved. The Company financed the acquisition with available cash. Based on 2015 operating results, the Company made a $4.6 payment in 2016. These brands are managed within the SPD segment.

The fair values of the net assets acquired are set forth as follows:

	2015
	VI-COR
Inventory and other working capital	$	1.1
Property, plant and equipment		6.4
Trade names and other intangibles		42.1
Goodwill		29.9
Purchase Price	$	79.5
Fair value of contingent payment due in one year		(4.6	)
Cash purchase price	$	74.9

The life of the amortizable intangible assets recognized from the VI-COR Acquisition ranges from 5 - 15 years. The goodwill is a result of expected synergies from combined operations of the acquired assets and the Company. Pro forma results are not presented because the impact is not material to the Company’s consolidated financial results.

On September 19, 2014, the Company acquired certain feminine care brands, including REPHRESH and REPLENS, from Lil’ Drug Store Products, Inc., (“Lil’ Drug Store Brands Acquisition”) for cash consideration of $215.7. The Company paid for the acquisition with additional debt. These feminine care brands are managed within the Consumer Domestic and Consumer International segments.

The fair values of the net assets acquired are set forth as follows:

	2014
	Lil' Drug Store
Inventory and other working capital	$	3.2
Property, plant and equipment		0.7
Trade names and other intangibles		109.0
Goodwill		102.8
Purchase Price	$	215.7

The life of the amortizable intangible assets recognized from the Lil’ Drug Store Brands Acquisition ranges from 5 - 20 years. The goodwill is a result of expected synergies from combined operations of the acquisition and the Company. Pro forma results are not presented because the impact is not material to the Company’s consolidated financial results.

The goodwill and other intangible assets associated with the Anusol Acquisition, the Toppik Acquisition, the VI-COR Acquisition, and Lil’ Drug Store Brands Acquisition are deductible for U.S. tax purposes.